Abstract:As an important kinase in multiple signal transduction pathways, GSK-3 has been an attractive target for chemical probe discovery and drug development. Compared to numerous reversible inhibitors that have been developed, covalent inhibitors of GSK-3 are noticeably lacking. Here, we report the discovery of a series of covalent GSK-3 inhibitors by optimizing both non-covalent interactions and reactive groups. Among these covalent inhibitors, compound 38b with a mild -fluoromethyl amide reactive group emerges as a selective and covalent inhibitor against GSK-3, effectively inhibits the phosphorylation of glycogen synthase and tau protein, and increases -catenin's levels in living cells. In addition, compound 38b is highly permeable and not a substrate of P-glycoprotein.

Design and synthesis of (aza)indolyl maleimide-based covalent inhibitors of glycogen synthase kinase 3 beta